Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Foundation Medicine Inc reaffirms FY 2014 revenue guidance


Wednesday, 7 May 2014 04:00pm EDT 

Foundation Medicine Inc:Continues to expect FY 2014 revenue in the range of $52 to $58 million.FY 2014 revenue of $58 mln - Thomson Reuters I/B/E/S. 

Company Quote

23.96
-0.03 -0.13%
26 Dec 2014